EF
ZYME icon

Empowered Funds’s Zymeworks ZYME Stock Holding History

Empowered Funds’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-360,044
Closed -$4.29M – 1869
2025
Q1 		$4.29M Buy
360,044
+7,291
+2% +$99.4K 0.06% 438
2024
Q4 		$5.16M Buy
352,753
+17,092
+5% +$239K 0.08% 365
2024
Q3 		$4.21M Buy
335,661
+17,018
+5% +$185K 0.07% 412
2024
Q2 		$2.71M Buy
318,643
+22,860
+8% +$203K 0.05% 507
2024
Q1 		$3.11M Buy
295,783
+22,367
+8% +$248K 0.06% 450
2023
Q4 		$2.84M Buy
273,416
+24,661
+10% +$197K 0.07% 396
2023
Q3 		$1.58M Buy
248,755
+20,382
+9% +$151K 0.05% 521
2023
Q2 		$1.97M Buy
+228,373
New +$2.04M 0.07% 398

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Empowered Funds's ZYME Position: Q2 2025 in Review

Empowered Funds sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 360,044 shares — an estimated $4.29M sold.

Empowered Funds first reported a position in ZYME in Q2 2023 and held it in 8 quarters. The position peaked at $5.16M in Q4 2024. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Empowered Funds reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Empowered Funds sold 360,044 Zymeworks shares in Q2 2025, an estimated $4.29M.
  • Empowered Funds first reported a position in Zymeworks in Q2 2023 and held it in 8 quarters.
  • Empowered Funds's Zymeworks position peaked at $5.16M in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Empowered Funds's 13F filing for Q2 2025, filed 11 Aug 2025.